Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$2.72M-92.7%$37.03M+3,585%$1.01M+112%-$8.23M+48.2%-$15.88M-1,945%
$16M+4.8%$15.27M+3.0%$14.82M+3.2%$14.36M+2.6%$14M+2.7%
$13.57M+2.0%$13.3M+12.1%$11.87M+3.1%$11.51M-0.2%$11.54M+9.1%
-$33.18M-848%$4.44M-68.8%
$13.67M-3.4%$14.15M+10.0%$12.86M-2.5%$13.19M+15.4%$11.44M+14.0%
-$13.67M+3.4%-$14.15M-10.0%-$12.86M+2.5%-$13.19M-15.4%-$11.44M-14.0%
-$35.52M-105%-$17.36M-182%$21.1M-28.8%$29.63M+5.1%$28.19M+2.0%
-$30.55M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Organogenesis Holdings Inc. generate?
Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
What is Organogenesis Holdings Inc.'s free cash flow?
After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
Where does Organogenesis Holdings Inc.'s cash flow data come from?
Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.